Statements (13)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:clinicalTrialPhase |
Phase 1
|
gptkbp:developedBy |
gptkb:Kymera_Therapeutics
|
https://www.w3.org/2000/01/rdf-schema#label |
KT-413
|
gptkbp:indication |
leukemia
hematologic malignancies |
gptkbp:mechanismOfAction |
IRAK4 degrader
|
gptkbp:routeOfAdministration |
intravenous
|
gptkbp:status |
investigational
|
gptkbp:target |
gptkb:IRAK4_protein
|
gptkbp:therapeuticArea |
oncology
|
gptkbp:bfsParent |
gptkb:Kymera_Therapeutics
|
gptkbp:bfsLayer |
7
|